Does Amneal (AMRX) Have the Potential to Rally 54.16% as Wall Street Analysts Expect?

Shares of Amneal Pharmaceuticals (AMRX) have gained 7% over the past four weeks to close the last trading session at $7.46, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $11.50 indicates a potential upside of 54.2%.The mean estimate comprises four short-term price targets with a standard deviation of $0.58. While the lowest estimate of $11 indicates a 47.5% increase from the c ...